Company Filing History:
1 out of 4,125 
1 out of 5 Years Active: 2005-2011
Title: Naoki Umezawa: Innovator in Antimalarial Compounds
Introduction
Naoki Umezawa is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial compounds. With a total of 2 patents, Umezawa's work focuses on creating effective treatments for malaria.
Latest Patents
Umezawa's latest patents include a compound with antimalarial activity and an antimalarial drug containing the same as an active ingredient. These compounds are represented by a specific chemical formula that includes various chemical groups and structures. Additionally, he has developed a method for delivering molecules to intracellular targets using β-peptides and β-peptide conjugates. These innovations allow for the effective transport of pharmacologically-active agents across cell membranes, enhancing their therapeutic potential.
Career Highlights
Throughout his career, Umezawa has worked with notable institutions such as the Wisconsin Alumni Research Foundation and Nagoya City University. His research has focused on the synthesis and application of compounds that exhibit high antimalarial activity, contributing to the fight against malaria.
Collaborations
Umezawa has collaborated with esteemed colleagues, including Samuel Helmer Gellman and Michael A Gelman. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medicinal chemistry.
Conclusion
Naoki Umezawa's contributions to the field of antimalarial research highlight his dedication to improving global health. His innovative patents and collaborative efforts continue to pave the way for advancements in the treatment of malaria.